Autres langues VitaSpring Biomedical Co. Ltd.

Actions

VSBC

US92851B1026

Marché Fermé - OTC Markets Autres places de cotation 20:03:41 11/08/2023			Varia. 5j.	Varia. 1 janv.
15 ^USD	+36,24 %		-.--%	-.--%

2022	VitaSpring Biomedical Co. Ltd. annonce les résultats de ses bénéfices pour le troisième trimestre et les neuf mois se terminant le 31 octobre 2022	CI
2022	VitaSpring Biomedical Co. Ltd. annonce ses résultats pour le deuxième trimestre et les six mois se terminant le 31 juillet 2022	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VITASPRING BIOMEDICAL CO. LTD. : Changes in Registrant's Certifying Accountant (form 8-K)	27/01/23
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	21/12/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	21/12/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/09/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	15/09/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/06/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2022	15/06/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	03/05/22
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Full Year Ended January 31, 2022	03/05/22
VitaSpring Biomedical Co. Ltd. Auditor Raises 'Going Concern' Doubt	03/05/22
VITASPRING BIOMEDICAL CO. LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	23/12/21
VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	23/12/21
QuantuMDx Group Limited announced that it has received ?15 million in funding from VitaSpring Biomedical Co. Ltd.	07/11/21
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	15/09/21
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter Ended July 31, 2021	15/09/21
VITASPRING BIOMEDICAL CO. LTD. : Change in Directors or Principal Officers (form 8-K)	11/08/21
Vitaspring Biomedical Co. Ltd. Announces Management Changes	11/08/21
VITASPRING BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	14/06/21
Vitaspring Biomedical Co. Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2021	14/06/21
VITASPRING BIOMEDICAL CO. LTD. : Unregistered Sale of Equity Securities (form 8-K)	22/04/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues VitaSpring Biomedical Co. Ltd.

Actions

VSBC

US92851B1026

Autres langues

Filtres